Skip to main content
Log in

Cancer therapeutics based on BCL-2 functional conversion

  • Perspective
  • Published:
Apoptosis Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Gupta D, Kumar M, Tyagi P, Kapoor S, Tyagi A, Barman TK, Kharbanda S, Kufe D, Singh H (2018) Concomitant delivery of paclitaxel and NuBCP-9 peptide for synergistic enhancement of cancer therapy. Nanomed Nanotechnol Biol Med 14(4):1301–1313

    Article  CAS  Google Scholar 

  2. Honma N, Horii R, Ito Y, Saji S, Younes M, Iwase T, Akiyama F (2015) Differences in clinical importance of Bcl-2 in breast cancer according to hormone receptors status or adjuvant endocrine therapy. BMC Cancer 15:698

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Kolluri SK, Zhu X, Zhou X, Lin B, Chen Y, Sun K, Tian X, Town J, Cao X, Lin F et al (2008) A short Nur77-derived peptide converts Bcl-2 from a protector to a killer. Cancer Cell 14:285–298

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Kumar M, Gupta D, Singh G, Sharma S, Bhat M, Prashant CK, Dinda AK, Kharbanda S, Kufe D, Singh H (2014) Novel polymeric nanoparticles for intracellular delivery of peptide Cargos: antitumor efficacy of the BCL-2 conversion peptide NuBCP-9. Cancer Res 74:3271–3281

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Pearce MC, Gamble JT, Kopparapu PR, O’Donnell EF, Mueller MJ, Jang HS, Greenwood JA, Satterthwait AC, Tanguay RL, Zhang X-K, Kolluri SK (2018) Induction of apoptosis and suppression of tumor growth by Nur77-derived Bcl-2 converting peptide in chemoresistant lung cancer cells. Oncotarget 9:26072–26085

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Siva Kumar Kolluri.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pearce, M.C., Satterthwait, A.C., Zhang, Xk. et al. Cancer therapeutics based on BCL-2 functional conversion. Apoptosis 24, 1–2 (2019). https://doi.org/10.1007/s10495-018-1504-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10495-018-1504-5

Navigation